Provider decisions to treat respiratory illnesses with antibiotics: Insights from a randomized controlled trial

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Branche, Angela R ^a   Walsh, Edward E ^a,b   Jadhav, Nagesh ^b   Karmally, Rachel ^b   Baran, Andrea ^c   Peterson, Derick R ^c   Falsey, Ann R ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN; ANTIINFECTIVE AGENT; CALCA PROTEIN, HUMAN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; PROTEIN PRECURSOR;

ADULT; AGE; AGED; ALGORITHM; ARTICLE; BLOOD CELL COUNT; CLINICAL PRACTICE; COMMUNITY HOSPITAL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEASIBILITY STUDY; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN CELL; KNOWLEDGE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MEDICOLEGAL ASPECT; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PATIENT ATTITUDE; PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCRIPTION; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SPUTUM CULTURE; TEACHING HOSPITAL; THORAX RADIOGRAPHY; CLINICAL DECISION MAKING; FACTOR ANALYSIS; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; PERCEPTION; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTIONS; UNITED STATES;

ALGORITHMS; ANTI-BACTERIAL AGENTS; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; CLINICAL DECISION-MAKING; FACTOR ANALYSIS, STATISTICAL; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH PERSONNEL; HUMANS; PERCEPTION; PHYSICIANS; PROTEIN PRECURSORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS; UNITED STATES;

EID: 84962834123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152986     Document Type: Article

References (49)

1. Fowlkes A, Giorgi A, Erdman D, Temte J, Goodin K, Di Lonardo S et al. Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the influenza incidence surveillance project, 2010-2011. J Infect Dis 2014;209:1715-25. doi: 10.1093/infdis/jit806 PMID: 24338352
2. Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev 2013;6:CD000247. doi: 10.1002/14651858. CD000247.pub3 PMID: 23733381
3. Tonkin-Crine S, Yardley L, Little P. Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta-ethnography. J Antimicrob Chemother 2011;66:2215-23. doi: 10. 1093/jac/dkr279 PMID: 21764827
4. Zimmerman RK, Rinaldo CR, Nowalk MP, Balasubramani GK, Moehling KK, Bullotta A et al. Viral infections in outpatients with medically attended acute respiratory illness during the 2012-2013 influenza season. BMC Infect Dis 2015;15:87, doi: 10.1186/s12879-015-0806-2 PMID: 25887948
5. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005; (4:): CD003539. PMID: 16235325
6. Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 2003;289:719-25. PMID: 12585950
7. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278:901-4. PMID: 9302241
8. van der Velden AW, Pijpers EJ, Kuyvenhoven MM, Tonkin-Crine SK, Little P, Verheij TJ. Effectiveness of physician-targeted interventions to improve antibiotic use for respiratory tract infections. Br J Gen Pract 2012;62:e801-7. doi: 10.3399/bjgp12X659268 PMID: 23211259
9. Yardley L, Douglas E, Anthierens S, Tonkin-Crine S, O'Reilly G, Stuart B et al. Evaluation of a webbased intervention to reduce antibiotic prescribing for LRTI in six European countries: quantitative process analysis of the GRACE/INTRO randomised controlled trial. Implement Sci 2013;8:134, doi: 10. 1186/1748-5908-8-134 PMID: 24238118
10. Roque F, Herdeiro MT, Soares S, Teixeira Rodrigues A, Breitenfeld L, Figueiras A. Educational interventions to improve prescription and dispensing of antibiotics: a systematic review. BMC Public Health 2014;14:1276, DOI: 2458-14-1276. doi: 10.1186/1471-2458-14-1276 PMID: 25511932
11. Charani E, Edwards R, Sevdalis N, Alexandrou B, Sibley E, Mullett D et al. Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review. Clin Infect Dis 2011;53:651-62. doi: 10.1093/cid/cir445 PMID: 21890770
12. Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis 2011;52 Suppl 4:S296-304. doi: 10.1093/cid/cir045 PMID: 21460288
13. Nolte FS. Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia. Clin Infect Dis 2008;47 Suppl 3:S123-6. doi: 10.1086/591392 PMID: 18986277
14. Lidman C, Burman LG, Lagergren A, Ortqvist A. Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia. Scand J Infect Dis 2002;34:873-9. PMID: 12587618
15. Falsey AR, Becker KL, Swinburne AJ, Nylen ES, Formica MA, Hennessey PA et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis 2013;208:432-41. doi: 10.1093/infdis/jit190 PMID: 23661797
16. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 2007;44 Suppl 2:S27-72. PMID: 17278083
17. Chandra A, Nicks B, Maniago E, Nouh A, Limkakeng A. A multicenter analysis of the ED diagnosis of pneumonia. Am J Emerg Med 2010;28:862-5. doi: 10.1016/j.ajem.2009.04.014 PMID: 20887906
18. Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 2007;131:1865-9. PMID: 17400668
19. Welker JA, Huston M, McCue JD. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med 2008;168:351-6. doi: 10.1001/archinternmed.2007.84 PMID: 18299488
20. Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273-80. PMID: 15796280
21. Paterson DL. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004;38 Suppl 4:S341-5. PMID: 15127367
22. Kruger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008;31:349-55. PMID: 17959641
23. Walsh EE, Swinburne AJ, Becker KL, Nylen ES, Snider RH, Baran A et al. Can serum procalcitonin levels help interpret indeterminate chest radiographs in patients hospitalized with acute respiratory illness?. J Hosp Med 2013;8:61-7. doi: 10.1002/jhm.1984 PMID: 23086568
24. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I et al. Effect of procalcitoninbased guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009;302:1059-66. doi: 10.1001/jama.2009.1297 PMID: 19738090
25. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013;13:426-35. doi: 10.1016/S1473-3099 (12) 70323-7 PMID: 23375419
26. Ruiz-Alvarez MJ, Garcia-Valdecasas S, De Pablo R, Sanchez García M, Coca C, Groeneveld TW et al. Diagnostic efficacy and prognostic value of serum procalcitonin concentration in patients with suspected sepsis. J Intensive Care Med 2009;24:63-71. doi: 10.1177/0885066608327095 PMID: 19054806
27. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7. PMID: 17317602
28. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8. PMID: 8094770
29. Leroy S, Adamsbaum C, Marc E, Moulin F, Raymond J, Gendrel D et al. Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection. Pediatrics 2005;115:e706-9. PMID: 15867014
30. Dubos F, Korczowski B, Aygun DA, Martinot A, Prat C, Galetto-Lacour A et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med 2008;162:1157-63. doi: 10.1001/archpedi.162.12.1157 PMID: 19047543
31. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171:1322-31. doi: 10.1001/archinternmed.2011.318 PMID: 21824946
32. Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). Arch Intern Med 2012;172:715-22. doi: 10.1001/archinternmed.2012.770 PMID: 22782201
33. Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis 2011;52:S362.
34. Fowler CL. ProCalcitonin for triage of patients with respiratory tract symptoms: A case study in the trial design process for approval of a new diagnostic test for lower respiratory tract infections. Clin Infect Dis 2011;52:S351. doi: 10.1093/cid/cir058 PMID: 21460295
35. Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S et al. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. Eur J Clin Microbiol Infect Dis 2013;32:51-60. doi: 10.1007/s10096-012-1713-8 PMID: 22886090
36. Branche AR, Walsh EE, Vargas R, Hulbert B, Formica MA, Baran A et al. Serum procalcitonin measurement and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: A randomized controlled trial. J Infect Dis 2015;212:1692-700. doi: 10.1093/infdis/jiv252 PMID: 25910632
37. Chapin KC, Murray PR. Stains. In: Murray PR, Barron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 7th ed. Washington, D. C: American Society for Microbioloty; 1999. p. 1677-79.
38. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis 2012;206:56-62. doi: 10.1093/infdis/jis309 PMID: 22529314
39. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005;352:1749-59. PMID: 15858184
40. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005;41:345-51. PMID: 16007532
41. Oosterheert JJ, van Loon AM, Schuurman R, Hoepelman AI, Hak E, Thijsen S et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 2005;41:1438-44. PMID: 16231254
42. Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med. 2007;167:354-60. PMID: 17242309
43. Shiley KT, Lautenbach E. Lee I. The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics? Infect Control Hosp Epidemiol. 2010;11:1177-1183.
44. Muller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007;7-10 PMID: 17335562
45. Boersma WG, Daniels JM, Lowenberg A, Boeve WJ, van de Jagt EJ. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respir Med 2006;100:926-32. PMID: 16337367
46. Basi SK, Marrie TJ, Huang JQ, Majumdar SR. Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes. Am J Med 2004;117:305-11. PMID: 15336579
47. Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2004;39:165-9. PMID: 15307023
48. Yang S, Lin S, Khalil A, Gaydos C, Nuemberger E, Juan G et al. Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol 2005;43:3221-6. PMID: 16000439
49. Suarez NM, Bunsow E, Falsey AR, Walsh EE, Mejias A, Ramilo O. Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults. J Infect Dis 2015;212:213-22. doi: 10.1093/infdis/jiv047 PMID: 25637350